Nalani J. Coleman

APLA Health — United States

Medicine · Health Sciences

2h-index10citations11works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(4), Cancer, Hypoxia, and Metabolism(4), Glioma Diagnosis and Treatment(3), Epigenetics and DNA Methylation(3), Immune Cell Function and Interaction(2)

Publications11 total

Abstract C045: ATRA promotes neutrophil aging and anti-tumor immune responses in murine models of non-small cell lung cancer
Cancer Immunology Research·2026
Abstract B007: Developing cytokine-armored CAR-NK cells for the treatment of non-small cell lung cancer
Cancer Immunology Research·2026
Abstract B089: Assessing integrin αvβ5 as a therapeutic target suppressing tumor progression and enhancing immune responses in non-small cell lung cancer
Cancer Immunology Research·2025
Abstract B068: A novel murine model for interrogating immune response to tumor heterogeneity in non-small cell lung cancer
Cancer Immunology Research·2025
Abstract B092: Mechanisms of PARP7 inhibition-induced tumor cell death: A novel therapeutic for non-small cell lung cancer with tumor-intrinsic and immune-dependent pathways
Cancer Immunology Research·2025
Abstract B009: Developing a platform for CEA-directed CAR-NK cells expressing IL-15 and CCL21 for the treatment of non-small cell lung cancer
Cancer Immunology Research·2025
Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms
Nature Communications·2024· 3 citedOpen Access
Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms
Research Square (Research Square)·2024Open Access
Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms
2024· 1 citedOpen Access
Capturing the Dynamic Conformational Changes of Human Isocitrate Dehydrogenase 1 (IDH1) upon Ligand and Metal Binding Using Hydrogen–Deuterium Exchange Mass Spectrometry
Biochemistry·2023· 6 citedOpen Access
Abstract 3732: Characterization of tumor relevant isocitrate dehydrogenase 1 (IDH1)
Cancer Research·2020

Frequent Co-authors

Bitta Kahangi(6), Camelia Dumitras(6), Jensen Abascal(6), Edgar Perez Reyes(6), Austin K. Rennels(6), Christal D. Sohl(5), Elene Albekioni(4), Diego Avellaneda Matteo(4), Elizabeth A. Komives(4), Steve Silletti(4), Ji-Ann Lee(4), Hong Jiang(4), Ramin Salehi‐Rad(4), Linh M. Tran(4), Kostyantyn Krysan(4), Kaitlyn A. Sabo(3), Matthew Mealka(3), Nicole A. Sierra(3), Rachel Khoury(3), Timothy Mai(3)